MedTrace Logo

ReFlow Medical Wingman Catheter Wing-IT Clinical Trial

NCT03403426 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2021-01-07

Study results available
· View outcomes & findings →

Summary

To evaluate the safety and effectiveness of the ReFlow Medical Wingman Catheter used to cross de novo or restenotic infrainguinal CTOs that cannot be crossed with a standard guidewire.

Conditions

  • Chronic Total Occlusion of Artery of the Extremities

Interventions

DEVICE

Wingman Crossing Catheter

Endovascular CTO crossing

Sponsors & Collaborators

  • ReFlow Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • John Laird, MD · Adventist St. Helena Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-13
Primary Completion
2019-08-08
Completion
2019-08-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03403426 on ClinicalTrials.gov